Maximising data capture in obesity trials
Global obesity trials are scaling fast with GLP‑1 therapies, making complete data capture essential to preserve scientific integrity and timelines. …
Post
-
-
GSK’s Nucala secures NICE COPD endorsement
In another landmark for GSK’s blockbuster respiratory drug, Nucala (mepolizumab), the UK’s health watchdog has recommended the therapy’s use by …
-
Radiopharma on the rise: Are supply chains ready?
Radiopharmaceutical therapies are moving from niche innovation to a mainstream oncology option. For supply chains built around stable, mass-produced medicines, …
-
Pfizer and Innovent Biologics sign $10.5bn cancer drug development deal
Pfizer and Innovent Biologics have signed a global licensing and collaboration agreement worth up to $10.5bn for the research and …
-
FDA grants priority review for Sanofi’s venglustat NDA
Sanofi has received a priority review from the US Food and Drug Administration (FDA) for its new drug application (NDA) …
-
Psychedelic-assisted therapies get a boost, but systems struggle to play catch-up
Following decades of stagnant research, psychedelic-assisted therapy has been heralded as a potentially transformative approach amid a global mental health …
-
FDA oncology roundup: AbbVie’s rare cancer approval, AstraZeneca in breast cancer limbo
As core operations at the US Food and Drug Administration (FDA) remain stable despite ongoing shifts in senior leadership, the …
-
Healthcare cost inflation is back in the headlines
Blockades by both Iran and the US in the Strait of Hormuz, as they negotiate an end to the conflict, …
-
Validation to velocity: Japan’s pharma model comes under execution pressure
Japan’s pharmaceutical industry - the world’s third largest by market value after the United States and China - has long …
-
California startup Protuoso raises $9.5m for “mix-and-match” drug platform
Protuoso Biosciences has secured $9.5m in seed financing to develop its platform which combines multiple therapeutic modalities to target diseases …
-
Kardigan targets IPO to support cardiology pipeline progression
Just under a year and a half after its debut, Kardigan is eyeing a listing on the Nasdaq to support …
-
Autobahn’s elunetirom receives FDA fast track designation to treat adjunctive bipolar
Autobahn Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for elunetirom, its lead central …
-
SK bioscience and VECOL partner on Colombia vaccine manufacturing initiative
SK bioscience has signed a vaccine technology transfer and manufacturing agreement with Colombia’s state-owned pharmaceutical company VECOL, becoming part of …
-
How price variation impacts employers
This is the first episode in our second season exploring the evolving landscape of real-world data and its role in …
-
Thinning revenues: inside the $14bn Eliquis patent cliff
Eliquis (apixaban) is one of the most commercially consequential loss-of-exclusivity (LOE) events in recent pharmaceutical history, with patent expiries expected …
